3-Acetylbenzeneboronic acid
Cas No: 204841-19-0
M.F: C8H9BO3
M.W: 163.97 |
|
Use : Pharmaceutical application |
Commercial |
|
4-Acetylbenzeneboronic acid
Cas No:149104-90-5
M.F:C8H9BO3
M.W.163.97 |
|
Use : Pharmaceutical application |
Development |
|
Allylboronic acid
Cas No:72824-04-5
M.F:C3H7BO2
M.W:85.96 |
|
Use : Pharmaceutical application |
Commercial |
|
3-Aminobenzeneboronic acid
Cas No: 30418-59-8
M.F: C6H8BNO2
M.W: 136.94 |
|
Use : Pharmaceutical application |
Development |
|
2-Amino-(4-methoxycarbonyl)benzeneboronic
Cas No: 380430-55-7
M.F: C8H11BCINO4
M.W: 231.44 |
|
Use : Pharmaceutical application
|
Development |
|
1,4-Benzenediboronic acid
Cas No: 4612-26-4
M.F: C6H8B2O4
M.w:165.75 |
|
Use : Pharmaceutical application |
Commercial |
|
N-Boc-Pyrrole-2-boronic acid
Cas No: 135884-31-0
M.F: C9H14BN04
M.W: 211.02 |
|
Use : : Pharmaceutical application |
Cmmercial |
|
4-(Bromomethyl)benzeneboronic acid pinacol ester
Cas No: 138500-85-3
M.F: C13H20BBrO3
M.W: 315.01 |
|
Use : : Pharmaceutical application |
Development |
|
4-(Bromomethyl)phenylboronic acid
Cas No: 68162-47-0
M.F: C7H7BBrO2
M.W: 214.85 |
|
Use : Pharmaceutical application |
Commercial |
|
4-tert-Butylbenzeneboronic acid
Cas No: 123324-71-0
M.F: C10H15BO2
M.W: 178.04 |
|
Use : Pharmaceutical application |
Commercial |
|
n-Butylboronic acid
Cas No: 4426-47-5
M.F: C4H11BO3
M.W: 101.94 |
|
Use : Pharmaceutical application |
Commercial |
|
3-Carboxyphenylboronic acid
Cas No: 25487-66-5
M.F: C7H7BO4
M.W: 165.94 |
|
Use : Pharmaceutical application |
Commercial |
|
4-carboxyphenylboronic acid
Cas No: 14047-29-1
M.F: C7H7BO4
M.W: 165.94 |
|
Use : Pharmaceutical application |
Commercial |
|
3-chlorophenylboronic acid
Cas No: 63503-60-6
M.F: C6H6BCIO2
M.W: 156.37 |
|
Use : Pharmaceutical application |
Commerical |
|
4-Chlorophenylboronic acid
Cas No: 1678-18-1
M.F: C6H6BCIO2
M.W: 156.37 |
|
Use : Pharmaceutical application |
Commercial |
|
2,4-Dichlorophenylboronic acid
Cas No: 68716-47-2
M.F: C6H5BCI2O2
M.W: 190.82 |
|
Use : Pharmaceutical application |
Commercial |
|
3,4-Dichlorophenylboronic acid
Cas No:151169-75-4
M.F:C6H5BCl2O2
M.w:190.82 |
|
Use : Pharmaceutical application |
Commercial |
|
2,3-Difluorobenzeneboronic acid
Cas No:121219-16-7
M.F:C6H5BF2O2
M.W:157.91 |
|
Use : Pharmaceutical application |
Commercial |
|
3,5-Difluorobenzeneboronic acid
Cas No:156545-076-2
M.F:C6H5BF2O2
M.W:157.91 |
|
Use : Pharmaceutical application |
Commercial |
|
2,5-Dimethoxybenzeneboronic acid
Cas No:107099-99-0
M.F:C8H11BO4
M.W:181.98 |
|
Use : Pharmaceutical application |
Commercial |
|
3,4-Dimethoxybenzeneboronic acid
Cas No:122775-35-3
M.F:C8H11BO4
M.w:181.98 |
|
Use : Pharmaceutical application |
Commercial |
|
2-[(2,2,Dimethyl !-oxoporpyl) amino] phenylboronic acid
Cas No:146140-95-6
M.F:C11H16BNO3
M.W:221.06 |
|
Use : Pharmaceutical application |
Commercial |
|
2-Fluorobenzeneboronic acid
Cas No:1993-03-9
M.F:C6H6BFO2
M.W:139.92 |
|
Use : Pharmaceutical application |
Commercial |
|
3-Fluoro-4-isoporpoxybenzeneboronic acid
Caas No:480438-54-8
M.F:C9H12BFO3
M.W:198.0 |
|
Use : Pharmaceutical application |
Commercial |
|
3-Fluoro-4-methoxybenzeneboronic acid
Cas No:149507-26-6
M.F:C7H8BFO3
M.W:169.95 |
|
Use : Pharmaceutical application |
Commercial |
|
5-Fluoro-2-methoxybenzeneboronic acid
Caas No:179897-94-0
M.F:C7H8BFO3
M.W:169.95 |
|
Use : Pharmaceutical application |
Commercial |
|
3-Fluorophenylboronic acid
Cas No:768-35-4
M.F:C6H6BFO2
M.W:139.92 |
|
Use : Pharmaceutical application |
Commercial |
|
4-Fluorophenylboronic acid
Cas No:1765-93-1
M.F:C6H6BFO2
M.W:139.92 |
|
Use : Pharmaceutical application |
Commercial |
|
3-Fluoro-4-propoxyphenylboronic acid
Cas No:192376-68-4
M.F:C9H12BFO3
M.W:198.0 |
|
Use : Pharmaceutical application |
Commercial |
|
5-Formyl-2-furanboronic acid
Cas No:27329-70-0
M.F:C5H5BO4
M.W:139.90 |
|
Use : Pharmaceutical application |
Commercial |
|
3-Formylphenylboronic acid
Cas No:87199-16-4
M.f:C7H7BO3
M.W:149.94 |
|
Use : Pharmaceutical application |
Commercial |
|
4-Formylphenylboronic acid
Cas No: 87199-17-5
M.F: C7H7BO3
M.W: 149.94 |
|
Use : Pharmaceutical application |
Commercial |
|
Furan-3-boronic acid
Cas No: 55552-70-0
M.F: C4H5BO3
M.W: 111.89 |
|
Use : Pharmaceutical application |
Development |
|
N-Hexylboronic acid
cas No: 16343-08-1
M.F: C6H15BO2
M.W: 129.99 |
|
Use : Pharmaceutical application |
Commercial |
|
3-Hydroxymethylbenzeneboronic acid
Cas No: 87199-15-3
M.F: C7H9BO3
M.W: 151.96 |
|
Use : Pharmaceutical application |
Commercial |
|
4-Hydroxymethylbenzeneboronic acid
Cas No: 59016-93-2
M.F: C7H9BO3
M.W:151.96 |
|
Use : Pharmaceutical application |
Commercial |
|
3-Hydroxyphenylboronic acid
Cas No: 87199-18-6
M.F:C6H7BFO3
M.W: 137.93 |
|
Use : Pharmaceutical application |
Commercial |
|
4-Hydroxyphenylboronic acid
Case No: 71597-85-8
M.F: C6H7BO3
M.W: 137.93 |
|
Use : Pharmaceutical application |
Commercial |
|
6-Hydroxy-2-napthaleneboronic acid
Cas No: 173194-95-1
M.F: C10H9BFO3
M.W: 187.99 |
|
Use : Pharmaceutical application |
Development |
|
Iodophenylboronic acid
Cas No: 5122-99-6
M.F: C6H6BIO2
M.W: 247.83 |
|
Use : Pharmaceutical application |
Development |
|
Isobutylboronic acid
Cas No: 84110-40-7
M.F: C4H11BO2
M.W: 101.94 |
|
Use : Pharmaceutical application |
Commercial |
|
Isopropenylboronic anhydride pyridine complex
Cas NO:
M.F: C9H15B3O3C5H5N
M.w: 282.75 |
|
Use : Pharmaceutical application |
Commercial |
|
Isopropylboronic acid
Cas No: 80041-89-0
M.F: C3H9BO2
M.W: 87.91 |
|
Use : Pharmaceutical application |
Development |
|
2-Isopropylbenzeneboronic acid
Cas No: 89787-12-2
M.F: C9H13BO2
M.W: 164.01 |
|
Use : Pharmaceutical application |
Commercial |
|
5-isoquinolineboronic acid
Cas No: 371766-08-4
M.F:C9H9B2NO4
M.W: 216.79 |
|
Use : Pharmaceutical application |
Development |
|
Isoquinolyl-4-yl boronic acid
Cas No: 192182-56-2
M.F: C9H9B2NO4
M.W: 216.79 |
|
Use : Pharmaceutical application |
Development |
|
Methaneboronic acid
Cas No: 13061-96-6
M.F: CH5BO2
M.W: 59.86 |
|
Use : Pharmaceutical application |
Development |
|
3-Methoxyphenylboronic acid
Cas No: 10365-98-7
M.F: C7H9BO3
M.W: 151.96 |
|
Use : Pharmaceutical application |
Commercial |
|
4-Methoxyphenylboronic acid
Cas No: 5720-07-0
M.F: C9H7BO3
M.W: 151.96 |
|
Use : Pharmaceutical application |
Commercial |
|
2-Methoxypyeidine-3-boronic acid
Cas No: 163105-89-3
M.F: C6H8BNO3
M.W: 152.94 |
|
Use : Pharmaceutical application |
Commercial |
|
2-Methoxy-5-pyridineboronic acid
Cas No: 163105-89-3
M.F: C6H8BNO3
M.W: 152.94 |
|
Use : Pharmaceutical application |
Commercial |
|
2-Methyl-1-propaneboronic acid
Cas No: 84110-40-7
M.F: C4H11BO2
M.W: 101.94 |
|
Use : Pharmaceutical application |
Commercial |
|
2-Methyl-3-pyridine-2-boronic acid
Cas No: 899436-71-6
M.F: C6H8BNO2
M.W: 136.94 |
|
Use : Pharmaceutical application |
Commercial |
|
3-Methylpyridine-2-boronic acid
Cas No: 930303-26-7
M.F: C6H8BNO2
M.W: 136.94 |
|
Use : Pharmaceutical application |
Commercial |
|
2-(Methylsulfonyl)benzeneboronic acid
Cas No: 373384-18-0
M.F: C7H9BO4S
M.W: 200.02 |
|
Use : Pharmaceutical application |
Commercial |
|
3-Nitrophenylboronic acid
Cas No: 13331-27-6
M.F: C6H6BNO4
M.W: 166.93 |
|
Use : Pharmaceutical application |
Commercial |
|
Phenylboronic acid
Cas No: 98-80-6
M.F: C6H7BO2
M.W: 121.93 |
|
Use : Pharmaceutical application .
Possible Intermediate for
Simvastatin/Vofopitant/Pirarubicin/Lasofoxifene |
Commercial |
|
Pyridyl-3-boronic acid
Cas No: 1692-25-7
M.F: C5H6BNO2
M.W: 122.92
|
|
Use : Pharmaceutical application |
Commercial |
|
Pyridine--4-boronic acid
Cas No: 1692-15-5
M.F: C5H6BNO2
M.W: 122.92 |
|
Use : Pharmaceutical application .
Possible Intermediate for Tirofiban HCL |
Commercial |
|
8-Quinoloneboronic acid
Caas No: 86-58-8
M.F: C9H8BNO2
M.W: 172.98 |
|
Use : Pharmaceutical application |
Commercial |
|
4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)
Cas No: 269410-08-4
M.F: C6H15BN2O2
M.W: 194.04 |
|
Use : Pharmaceutical application |
Development |
|
Thiophene-2-boronic acid
Cas No: 6165-68-0
M.F:C4H5BO2S
M.W: 127.96 |
|
Use : Pharmaceutical application |
Development |
|
Thiophene-3boronic acid
Cas No: 6165-69-1
M.F: C4H5BO2S
M.W: 127.96 |
|
Use : Pharmaceutical application |
Commercial |
|
2-Tolylboronic acid
Cas No: 16419-60-6
M.F: C7H9BO2
M.W: 135.96 |
|
Use : Pharmaceutical application.
Possible Intermediate for Netupitant/Bofetupitant |
Commercial |
|
3-Tolylboronic acid
Cas No: 17933-03-8
M.F: C7H9BO2
M.W: 135.96 |
|
Use : Pharmaceutical application.
Possible Intermediate For Eltrombopag |
Commercial |
|
4-Tolylboronic acid
Case No: 5720-05-8
M.F: C7H9BO2
M.W: 135.96 |
|
Use : Pharmaceutical application.
Possible Intermediate For Condesartan Cilexetil Telmisartan/Irbesartan |
Commercial |
|
3-Trifluoromethylphenylboronic acid
Cas No: 1423-26-3
M.F: C7H6BF3O2
M.W: 189.93 |
|
Use : Pharmaceutical application. |
Development |
|
4-Trifluoromethylphenylboronic acid
Cas No: 128796-39-4
M.F: C7H6BF3O2
M.W: 189.93 |
|
Use : Pharmaceutical application. |
Development |
|
2,4,6- Trimethylbenzeneboronic acid
Cas No: 5980-97-2
M.F: C6H13BO2
M.W: 164.01 |
|
Use : Pharmaceutical application. |
Commercial |
|
2,4,6-Tris (3,5 Difluorophenyl) boroxin
Cas No: 218963-15-6
M.f: C22H12BF6O
M.W: 419.69 |
|
Use : Pharmaceutical application. |
Development |
|
Vinyl Boronic anydride Pyridine complex
Cas No: 442850-89-7
M.F: C6H9B3O3C5H5N
M.W: 240.67 |
|
Use : Pharmaceutical application. |
Development |
|